ARIVA Med GmbH
PrivateLast Round
Grant
May 1, 2025
Total Funding Raised
$11,000
Company Overview
ARIVA Med GmbH is a biopharmaceutical company that develops novel anti-infectives to address antimicrobial resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ARIVA Med GmbH Comparables
Compare ARIVA Med GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kinvard Bio | 82% | |
| Antabio | 78% | |
| Obulytix | 77% |
ARIVA Med GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2025 | ||||
| Grant | Aug 1, 2024 |
ARIVA Med GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vienna Business Agency | Grant |
| INCATE | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Received grant funding from Vienna Business Agency.
- Aug 1, 2024
$11K grant received from INCATE.
ARIVA Med GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ARIVA Med GmbH's valuation, stock price, and market status.
Is ARIVA Med GmbH a public or private company?
ARIVA Med GmbH is a private company.
What is the current stock price of ARIVA Med GmbH?
ARIVA Med GmbH is a private company, so its shares have no public market price. Caplight tracks ARIVA Med GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ARIVA Med GmbH worth (valuation)?
Valuation information for ARIVA Med GmbH is not publicly available.
Can I buy ARIVA Med GmbH stock?
ARIVA Med GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ARIVA Med GmbH's last funding round?
ARIVA Med GmbH's most recent funding round was Grant on May 1, 2025.
Who are the main investors in ARIVA Med GmbH?
Key investors in ARIVA Med GmbH include Vienna Business Agency, INCATE.
Will ARIVA Med GmbH IPO soon?
No public IPO plans have been announced for ARIVA Med GmbH.
How can I track ARIVA Med GmbH secondary market activity?
Caplight tracks bids, offers, and trades in ARIVA Med GmbH's shares on secondary markets.